ProetoWise developed a 3-dimensional nanoscale protein capture. By binding proteins covalently in rigid nanoporous structures, 3-dimensional nanoscale protein capture can be rapidly and repeatedly addressed with antibody probes. This solves all the problems of western blot while providing molecular weight and identity information that researchers need.
Missing: ProteoWise's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ProteoWise's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
ProteoWise Frequently Asked Questions (FAQ)
When was ProteoWise founded?
ProteoWise was founded in 2018.
Where is ProteoWise's headquarters?
ProteoWise's headquarters is located at 34 Bryan Road, Branford.
What is ProteoWise's latest funding round?
ProteoWise's latest funding round is Series B.
How much did ProteoWise raise?
ProteoWise raised a total of $8.95M.
Who are the investors of ProteoWise?
Investors of ProteoWise include Connecticut Innovations and Foothill Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.